Free tool
Stocks above their 200-day average
We cover 439 companies trading above their own 200-day average. The median market value in the group is $70.31M. Across the group, the median move over the past trading day is 0.00%. 100% of the 439 with a 200-day average trade above it. Price change over the past year runs from −28.8% to +225.6% across the middle 80 percent of the group, with a median of +20.8%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
439 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −5.53% |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% |
| 4523.T | Eisai Co., Ltd. | $8.48B | Mid cap | +7.64% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.74% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| BLCO.TO | Bausch + Lomb Corporation | $6.18B | Mid cap | +19.34% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.63B | Mid cap | +66.34% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% |
| TLX | Telix Pharmaceuticals Limited | $3.77B | Mid cap | −8.02% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.74B | Mid cap | +21.45% |
| 7459.T | MediPal Holdings Corporation | $3.72B | Mid cap | +13.38% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% |
| CURA.TO | Curaleaf Holdings, Inc. | $2.51B | Mid cap | +197.74% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| BHC.TO | Bausch Health Companies Inc. | $2.43B | Mid cap | −9.88% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | −2.24% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.36B | Mid cap | +112.62% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +146.56% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +45.23% |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.11B | Mid cap | +2.80% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
| NANOFH.HE | Nanoform Finland Oyj | $95.78M | Micro cap | +15.66% |
| ILA.AX | Island Pharmaceuticals Limited | $95.70M | Micro cap | +109.30% |
| 004080.KS | Shinhung Co., Ltd | $94.21M | Micro cap | +2.54% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| NANOFS.ST | Nanoform Finland Oyj | $93.63M | Micro cap | +19.56% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| BIOPOR.CO | BioPorto A/S | $93.40M | Micro cap | −3.13% |
| ECOR | electroCore, Inc. | $93.31M | Micro cap | +86.49% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | $91.93M | Micro cap | +15.88% |
| ICCC | ImmuCell Corporation | $91.00M | Micro cap | +64.26% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | $89.79M | Micro cap | −23.84% |
| EAH.L | ECO Animal Health Group plc | $89.77M | Micro cap | +34.69% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| 194A.T | WOLVES HAND CO LTD | $88.72M | Micro cap | +102.92% |
| NANEXA.ST | Nanexa AB (publ) | $87.59M | Micro cap | +100.43% |
| ATHE | Alterity Therapeutics Limited | $86.64M | Micro cap | −4.40% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | $86.56M | Micro cap | +78.27% |
| BB1.AX | BLINKLAB FPO [BB1] | $86.46M | Micro cap | +47.22% |
| CREO.L | Creo Medical Group PLC | $85.82M | Micro cap | −1.90% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +29.19% |
| 7792.T | Colan Totte.Co.,Ltd. | $84.83M | Micro cap | +6.32% |
| ACET | Adicet Bio, Inc. | $83.79M | Micro cap | −26.01% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| HIGH.DE | Cantourage Group SE | $81.55M | Micro cap | +51.90% |
| OBI.L | Ondine Biomedical Inc. | $81.20M | Micro cap | −24.19% |
| INIFY.OL | INIFY Laboratories AB | $81.09M | Micro cap | +44.55% |
| ATH.AX | Alterity Therapeutics Limited | $80.50M | Micro cap | −14.17% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +320.55% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.25% |
| NRXS | NeurAxis, Inc. | $74.84M | Micro cap | +146.28% |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% |
| KOO.L | Kooth plc | $72.00M | Micro cap | −7.59% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +131.74% |
| ALTHX.PA | THX Pharma Société Anonyme | $71.22M | Micro cap | +73.96% |
| 4875.T | MediciNova, Inc. | $71.04M | Micro cap | +11.17% |
| 7702.T | JMS Co.,Ltd. | $70.66M | Micro cap | +6.20% |
| ZLNA.OL | Zelluna ASA | $70.31M | Micro cap | +56.57% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| 9341.T | GENOVA, Inc. | $68.87M | Micro cap | +1.56% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.16M | Micro cap | +1.97% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −47.29% |
| AVE.AX | Avecho Biotechnology Limited | $66.64M | Micro cap | +300.00% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| 2934.T | J Frontier Co.,Ltd. | $65.60M | Micro cap | −2.11% |
| TLPH | Talphera, Inc. | $65.40M | Micro cap | +133.33% |
| R0L.F | J Frontier Co.,Ltd. | $64.05M | Micro cap | −44.02% |
| MYO | Myomo, Inc. | $60.60M | Micro cap | +36.61% |
| INKT | MiNK Therapeutics, Inc. | $60.16M | Micro cap | −26.22% |
| 9265.T | Yamashita Health Care Holdings,Inc. | $59.83M | Micro cap | +24.40% |
| XLO | Xilio Therapeutics, Inc. | $59.55M | Micro cap | −5.63% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | $57.90M | Micro cap | −0.72% |
| 4524.T | Morishita Jintan Co., Ltd. | $57.77M | Micro cap | +4.22% |
| COCH | Envoy Medical, Inc. | $56.82M | Micro cap | −37.09% |
| 4896.T | K Pharma,Inc. | $56.45M | Micro cap | +14.56% |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% |
| ALTHE.PA | Theraclion SA | $55.29M | Micro cap | −22.30% |
| ALSMA.PA | S.M.A.I.O S.A. | $54.96M | Micro cap | +14.29% |
| NTRB | Nutriband Inc. | $54.70M | Micro cap | −29.80% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| ATX.AX | Amplia Therapeutics Limited | $54.23M | Micro cap | −14.71% |
| EPIS-B.ST | Episurf Medical AB (publ) | $53.85M | Micro cap | +71.52% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| 4572.T | Carna Biosciences, Inc. | $53.63M | Micro cap | +81.90% |
| MOB.ST | Moberg Pharma AB (publ) | $53.40M | Micro cap | +32.92% |
| 9218.T | Mental Health Technologies Co.,Ltd. | $51.69M | Micro cap | −7.41% |
| 4597.T | Solasia Pharma K.K. | $51.40M | Micro cap | −18.92% |
| ENP.AX | Entropy Neurodynamics Limited | $48.13M | Micro cap | +10.81% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| MLSS | Milestone Scientific Inc. | $47.87M | Micro cap | −10.10% |
| 3628.T | Data Horizon Co.,Ltd. | $47.15M | Micro cap | +7.64% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −33.72% |
| IMMU.ST | Mendus AB (publ) | $46.19M | Micro cap | −4.57% |
| CLBIO.ST | Corline Biomedical AB | $45.27M | Micro cap | +45.56% |
| ELUT | Elutia Inc. | $44.29M | Micro cap | −54.75% |
| 9340.T | ASO International, Inc. | $44.19M | Micro cap | +0.18% |
| NEPH | Nephros, Inc. | $43.98M | Micro cap | 0.00% |
| CTE.AX | Cryosite Limited | $43.85M | Micro cap | +56.25% |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% |
| ALCOX.PA | Nicox S.A. | $43.02M | Micro cap | +2.70% |
| ALNOV.PA | Novacyt S.A. | $42.69M | Micro cap | +7.38% |
| NCYT.L | Novacyt S.A. | $42.07M | Micro cap | +7.81% |
| 4893.T | Noile-Immune Biotech Inc. | $40.36M | Micro cap | −16.38% |
| 206A.T | PRISM BioLab Co.,LTD | $39.48M | Micro cap | −5.56% |
| 002630.KS | ORIENT BIO Inc. | $39.42M | Micro cap | +49.67% |
| PKY.AX | Pathkey.AI Ltd | $38.82M | Micro cap | +77.27% |
| IVACC.ST | Intervacc AB (publ) | $38.50M | Micro cap | +4.78% |
| 7980.T | Shigematsu Works Co., Ltd. | $38.11M | Micro cap | +6.69% |
| MVP.AX | Medical Developments International Limited | $37.65M | Micro cap | −19.83% |
| 7707.T | Precision System Science Co., Ltd. | $37.57M | Micro cap | +6.34% |
| 7681.T | LEOCLAN Co.,Ltd. | $37.16M | Micro cap | −10.99% |
| ALMKT.PA | Mauna Kea Technologies SA | $37.11M | Micro cap | +47.33% |
| ABDX.L | Abingdon Health Plc | $36.92M | Micro cap | +104.76% |
| 7091.T | Living Platform,Ltd. | $36.16M | Micro cap | +34.42% |
| SPRINT.ST | Sprint Bioscience AB (publ) | $35.56M | Micro cap | +458.51% |
| ALGEN.PA | genOway Société anonyme | $35.25M | Micro cap | −18.00% |
| BIOWKS.ST | Bio-Works Technologies AB (publ) | $35.21M | Micro cap | +4.75% |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% |
| PTG.WA | Poltreg S.A. | $34.78M | Micro cap | −14.68% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −3.19% |
| NSYS | Nortech Systems Incorporated | $33.62M | Micro cap | +30.74% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| PXS.L | Provexis plc | $32.52M | Micro cap | +51.39% |
| 4172.T | Hi-CRATES CO.,LTD. | $32.39M | Micro cap | +3.74% |
| BRAIN.ST | BrainCool AB (publ) | $32.34M | Micro cap | −21.51% |
| SIGHT.PA | GenSight Biologics S.A. | $32.26M | Micro cap | −25.31% |
| RMTI | Rockwell Medical, Inc. | $31.90M | Micro cap | +438.44% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| IGC | IGC Pharma, Inc. | $31.49M | Micro cap | −31.62% |
| ALDVI.PA | Advicenne S.A. | $30.93M | Micro cap | +39.11% |
| 4591.T | Ribomic Inc. | $30.52M | Micro cap | −17.31% |
| NXN.AX | Nexsen Ltd | $30.21M | Micro cap | −25.00% |
| MBX.TO | Microbix Biosystems Inc. | $30.10M | Micro cap | +27.08% |
| EYE.AX | Nova Eye Medical Limited | $29.60M | Micro cap | +3.45% |
| GDR.L | genedrive plc | $28.91M | Micro cap | +67.74% |
| BRNS | Barinthus Biotherapeutics plc | $28.86M | Micro cap | −38.04% |
| GRDX | GridAI Technologies Corp. | $28.75M | Micro cap | +111.52% |
| NN6.DE | NanoRepro AG | $27.65M | Micro cap | −4.90% |
| 6545.T | internet infinity Inc. | $27.61M | Micro cap | +34.23% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | $27.48M | Micro cap | −44.31% |
| SOFTX.OL | SoftOx Solutions AS | $27.33M | Micro cap | −15.04% |
| ISOFOL.ST | Isofol Medical AB (publ) | $26.92M | Micro cap | −1.87% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | $26.60M | Micro cap | +97.38% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| OSL.AX | OncoSil Medical Limited | $25.86M | Micro cap | +0.87% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% |
| MRKR | Marker Therapeutics, Inc. | $24.18M | Micro cap | +54.26% |
| RUA.L | RUA Life Sciences plc | $24.04M | Micro cap | +130.93% |
| FEMY | Femasys Inc. | $23.87M | Micro cap | +711.11% |
| LABS.TO | MediPharm Labs Corp. | $23.16M | Micro cap | +6.67% |
| ALTAO.PA | Aton | $22.75M | Micro cap | +153.85% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| 4884.T | Kringle Pharma, Inc. | $22.30M | Micro cap | −11.29% |
| RVP | Retractable Technologies, Inc. | $21.85M | Micro cap | −12.05% |
| COCP | Cocrystal Pharma, Inc. | $21.57M | Micro cap | −27.74% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $21.32M | Micro cap | −15.72% |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | +0.03% |
| 7129.T | Miahelsa Holdings Corporation | $20.31M | Micro cap | +4.87% |
| RHT.AX | Resonance Health Limited | $20.23M | Micro cap | +43.90% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
| DEX.ST | Dextech Medical AB | $20.09M | Micro cap | +26.38% |
| NOX.AX | Noxopharm Limited | $19.87M | Micro cap | −10.00% |
| NCEL | NewcelX Ltd. | $19.52M | Micro cap | −84.77% |
| 9220.T | FB Care Service Co.,Ltd. | $19.37M | Micro cap | +11.55% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| ALBIO.PA | Biosynex SA | $19.25M | Micro cap | −23.23% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| 5619.T | MRSO INC | $18.85M | Micro cap | −16.43% |
| LEXX | Lexaria Bioscience Corp. | $18.24M | Micro cap | +1146.05% |
| ALINS.PA | Intrasense S.A. | $18.05M | Micro cap | −0.34% |
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| CYCN | Cyclerion Therapeutics, Inc. | $17.97M | Micro cap | +61.48% |
| ALTME.PA | TME Pharma N.V. | $17.97M | Micro cap | +25.97% |
| BIVI | BioVie Inc. | $17.83M | Micro cap | +30.25% |
| ALZ.ST | Alzinova AB (publ) | $17.74M | Micro cap | −39.02% |
| 7813.T | Platz Co., Ltd. | $17.74M | Micro cap | +18.51% |
| ABERA.ST | Abera Bioscience AB | $17.69M | Micro cap | +1.61% |
| ADIL | Adial Pharmaceuticals, Inc. | $17.43M | Micro cap | −37.47% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | $17.00M | Micro cap | +3.31% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| ALEMG.PA | Laboratoires Euromedis Société anonyme | $16.52M | Micro cap | +18.10% |
| 6063.T | Emergency Assistance Japan Co., Ltd. | $15.79M | Micro cap | +0.89% |
| THAT.L | Thalia Therapeutics Plc | $15.69M | Micro cap | +52.94% |
| BTC.AX | BTC Health Limited | $15.67M | Micro cap | −1.61% |
| ADVB | Advanced Biomed Inc. | $15.27M | Micro cap | +13.24% |
| ORTI-B.ST | Ortivus AB (publ) | $15.21M | Micro cap | +42.11% |
| ICR.AX | Intelicare Holdings Limited | $14.91M | Micro cap | +75.76% |
| ACTI.ST | Active Biotech AB (publ) | $14.50M | Micro cap | −62.00% |
| OBSRV.OL | Observe Medical ASA | $14.28M | Micro cap | +5.05% |
| NTI.AX | Neurotech International Limited | $14.26M | Micro cap | +15.38% |
| 189A.T | D&M COMPANY CO LTD | $14.10M | Micro cap | +9.26% |
| 7083.T | AHC Group Inc. | $14.05M | Micro cap | +16.95% |
| PHIO | Phio Pharmaceuticals Corp. | $13.94M | Micro cap | −40.89% |
| IDT.AX | IDT Australia Limited | $13.82M | Micro cap | −30.77% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.67M | Micro cap | −30.12% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | $13.60M | Micro cap | −28.35% |
| HSCS | HeartSciences Inc. | $13.47M | Micro cap | −11.54% |
| ICO.ST | Iconovo AB (publ) | $12.72M | Micro cap | −52.09% |
| NXTCL.ST | NextCell Pharma AB | $12.42M | Micro cap | −5.10% |
| 6029.T | Artra Group Corporation | $12.41M | Micro cap | −19.57% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| ARCOMA.ST | Arcoma AB | $12.17M | Micro cap | −2.13% |
| ALBPS.PA | Biophytis S.A. | $11.98M | Micro cap | −50.31% |
| ASBP | Aspire Biopharma Holdings, Inc. | $11.68M | Micro cap | −60.93% |
| KPRX | Kiora Pharmaceuticals, Inc. | $11.46M | Micro cap | −9.44% |
| TOVX | Theriva Biologics, Inc. | $11.16M | Micro cap | −42.10% |
| ALAMA.PA | AMA Corporation Plc | $10.27M | Micro cap | −34.56% |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% |
| IDLDX.ST | IDL Diagnostics AB (publ) | $9.63M | Micro cap | −2.36% |
| MBAI | Check-Cap Ltd. | $9.33M | Micro cap | +943.08% |
| BMGL | Basel Medical Group Ltd | $9.29M | Micro cap | +202.81% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −35.77% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| XWEL | XWELL, Inc. | $8.55M | Micro cap | −6.93% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −13.51% |
| 7362.T | Terminalcare Support Institute Inc. | $8.43M | Micro cap | +3.53% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | $8.30M | Micro cap | −0.39% |
| PRE.MI | Predict S.p.A. | $8.17M | Micro cap | +7.51% |
| NDRA | ENDRA Life Sciences Inc. | $8.16M | Micro cap | +32.36% |
| ALZN | Alzamend Neuro, Inc. | $8.06M | Micro cap | −32.11% |
| NVNO | enVVeno Medical Corporation | $7.97M | Micro cap | −63.76% |
| ICCM | IceCure Medical Ltd | $7.85M | Micro cap | +132.49% |
| TRIB | Trinity Biotech plc | $7.80M | Micro cap | +547.97% |
| PILA.ST | Pila Pharma AB (publ) | $7.79M | Micro cap | −15.41% |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% |
| CODE.OL | CodeLab Capital AS | $7.42M | Micro cap | +22.74% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| 011000.KS | GeneOne Life Science, Inc. | $7.01M | Micro cap | +18.40% |
| IXC.AX | Invex Therapeutics Ltd | $7.00M | Micro cap | +30.00% |
| JUNS | Jupiter Neurosciences, Inc. | $6.66M | Micro cap | +236.24% |
| VBS.AX | Vectus Biosystems Limited | $6.65M | Micro cap | +104.82% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | $6.35M | Micro cap | −85.49% |
| CTQ.AX | Careteq Limited | $6.32M | Micro cap | +20.00% |
| AMIX | Autonomix Medical, Inc. | $6.20M | Micro cap | +440.68% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +46.03% |
| PEXA-B.ST | PExA AB (publ) | $6.18M | Micro cap | +79.47% |
| STRAP.CO | Strategic Partners A/S | $5.82M | Micro cap | −28.50% |
| CSCI.TO | COSCIENS Biopharma Inc. | $5.24M | Micro cap | +60.79% |
| SERV.ST | Servana AB | $5.18M | Micro cap | +106.67% |
| FLUI.ST | Fluicell AB (publ) | $5.06M | Micro cap | +247.74% |
| HCWB | HCW Biologics Inc. | $4.96M | Micro cap | −55.15% |
| XAIR | Beyond Air, Inc. | $4.89M | Micro cap | +117.98% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| APS.TO | Aptose Biosciences Inc | $4.41M | Micro cap | +50.00% |
| SILO | Silo Pharma, Inc. | $4.38M | Micro cap | +290.62% |
| AINO.ST | Aino Health AB (publ) | $4.25M | Micro cap | −10.81% |
| ADR.AX | Adherium Limited | $3.93M | Micro cap | +1900.00% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | $3.53M | Micro cap | +11.79% |
| UPC | Universe Pharmaceuticals INC | $3.53M | Micro cap | +44.57% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.49M | Micro cap | −19.16% |
| TNON | Tenon Medical, Inc. | $3.48M | Micro cap | +297.71% |
| GNPX | Genprex, Inc. | $3.25M | Micro cap | −54.10% |
| PYC.L | Physiomics Plc | $3.17M | Micro cap | +21.18% |
| MONSO.CO | Monsenso A/S | $3.14M | Micro cap | +23.81% |
| SPERM.ST | Spermosens AB (publ) | $3.13M | Micro cap | +15.79% |
| TD1.AX | TALi Digital Limited | $3.02M | Micro cap | −10.00% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
| PFSA | Profusa, Inc. | $2.58M | Micro cap | −86.13% |
| VRAX | Virax Biolabs Group Limited | $2.21M | Micro cap | +365.55% |
| PHAL.ST | PharmaLundensis AB | $2.14M | Micro cap | +37.83% |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $2.10M | Micro cap | +7.65% |
| MNDR | Mobile-health Network Solutions | $1.92M | Micro cap | −69.91% |
| RESP.ST | Respiratorius AB (publ) | $1.89M | Micro cap | −39.20% |
| 27N0.DE | Cannovum Cannabis AG | $1.71M | Micro cap | +22.47% |
| BIG1.DE | Bio-Gate AG | $1.55M | Micro cap | +200.53% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.48M | Micro cap | +93.92% |
| ALINT.PA | IntegraGen SA | $1.38M | Micro cap | −36.25% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
| ALNEV.PA | Neovacs S.A. | $22.00 | Micro cap | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.